Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
23 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Trillium Therapeutics Inc. (TTI), formerly Neurogenesis Biotech Corp., is a biopharmaceutical company which focuses on the development of novel therapies for the treatment of cancer. The companys pre-clinical programs include SIRPaFc and a CD200 monoclonal antibody. Its SIRPaFc is currently in pre-clinical development used for the treatment of acute myeloid leukemia. TTIs CD200 is an immunosuppressive molecule used by many tumors to evade the immune system. The company offers CD47 which binds SIRPaFc on the surface of macrophages and transmits do not eat signal that protects cells from macrophage attack.

Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals in

  
Source:
Document ID
GDPH139362D
Country
Industry
Ticker
TR=CA
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Trillium Therapeutics Inc., Pharmaceuticals &Healthcare, Deal Details1010
  Venture Financing101
    Fluorinov Pharma Raises US$1.5 Million In Venture Financing101
    Trillium Therapeutics Secures US$1.1 Million In Venture Financing111
  Merger121
    Stem Cell Therapeutics Completes Merger With Trillium Therapeutics121
  Licensing Agreements131
    Trillium Enters Into Licensing Agreement With UHN and SickKids For Hematopoietic Stem Cell Transplantation132
    Trillium Enters Into Licensing Agreement With UHN and SickKids For Cancer151
    Trillium Therapeutics Enters Into Licensing Agreement With Biogen Idec161
  Equity Offering171
    Trillium Therapeutics Raises USD55.2 Million in Public Offering of Shares172
  Acquisition191
    Trillium Therapeutics to Acquire Fluorinov Pharma191
Trillium Therapeutics Inc. - Key Competitors201
Key Employees211
Locations And Subsidiaries221
  Head Office221
  Other Locations &Subsidiaries221
Appendix231
  Methodology231
  About GlobalData231
  Contact Us231
  Disclaimer231

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Trillium-Therapeutics-Inc-TR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6705>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Trillium Therapeutics Inc. (TR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Trillium-Therapeutics-Inc-TR-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6705>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research